하나로의료재단 블로그

2026-05-29

[Press Release] SCL Group and Hanaro Medical Foundation Integrate K-Health into Indonesia's National Central Hospital

SCL Group and Hanaro Medical Foundation signed an MOU with Indonesia's RSCM to cooperate on advanced medical services, precision diagnostics, and AI solutions.

[Press Release] SCL Group and Hanaro Medical Foundation Integrate K-Health into Indonesia's National Central Hospital

[Press Release] SCL Group and Hanaro Medical Foundation Integrate K-Health into Indonesia’s National Central Hospital

Hello. This is Hanaro Medical Foundation.

SCL Group and Hanaro Medical Foundation have signed a Memorandum of Understanding (MOU) with RSUP Cipto Mangunkusumo (RSCM), Indonesia’s National Central Hospital, for cooperation in advanced medical services and diagnostics. RSCM is the representative national hospital of Indonesia, and this partnership marks the first collaborative case between a Korean medical institution and Indonesia in the field of diagnostic medicine.

Under this agreement, both institutions plan to promote priority cooperation and exchanges in mid-to-long-term overseas business areas, including: △Precision diagnostics such as early multi-cancer screening and genetic testing △AI-based early diagnosis solutions △Joint utilization of medical equipment such as MRI and CT △K-Healthcare, LAB, and IT platforms.

In particular, as there is high local demand for services focused on early diagnosis and preventive medicine, various business expansions such as health screenings and data-based medical services are expected in the future.

This collaboration is anticipated to serve as a significant milestone for entering the Southeast Asian market and expanding our global medical network.

📰 Hanaro Medical Foundation in the Press 📰

SCL Group and Hanaro Medical Foundation Integrate K-Health into Indonesia’s National Central Hospital. SCL Group signs an agreement with Indonesia’s National Central Hospital to promote cooperation in precision diagnostics and AI medicine. Expansion into the Southeast Asian healthcare market is expected. v.daum.net

SCL Group and Hanaro Medical Foundation Sign MOU with Indonesia’s National Central Hospital. SCL Group (Chairman Lee Kyung-ryul), a provider of comprehensive healthcare solutions, signed an MOU for cooperation in advanced medical services and diagnostics with Indonesia’s National Central Hospital (RSUP). v.daum.net

‘K-Medical’ Expands Territory in Southeast Asia... SCL Group Signs MOU with Indonesia’s National Central Hospital - Maeil Business Newspaper. Transplanting Korean-style health screenings locally. v.daum.net

SCL Group and Hanaro Medical Foundation Join Hands with Indonesia’s National Central Hospital... ‘Healthcare Cooperation’. Photo source = SCL Group. SCL Group signed an MOU for cooperation in medical services and diagnostics with Indonesia’s representative Cipto Mangunkusumo National Central Hospital (RSCM) today (28th). v.daum.net

SCL Group Cooperates with Indonesian National Hospital... Full-scale Entry into Southeast Asia. SCL Group, which has expanded its business based on diagnostic testing and health screenings, secures a bridgehead for medical exports and begins its Southeast Asian offensive through cooperation with Indonesia’s core medical institution. Future revenue models can expand to diagnostic services, health screening programs, and data-based medical platforms. v.daum.net

SCL Group and Hanaro Medical Foundation Integrate K-Health into Indonesia’s National Central Hospital - The Korean Doctors’ Weekly. SCL Group (Chairman Lee Kyung-ryul) signed an MOU for cooperation in advanced medical services and diagnostics with Indonesia’s National Central Hospital. Through this agreement, both institutions will focus on precision diagnostics such as early multi-cancer screening and genetic testing... cp.news.search.daum.net

#HanaroMedicalFoundation #HealthScreening #Indonesia #IndonesiaNationalCentralHospital #RSCM #KHealthcare

Frequently Asked Questions

Where did SCL Group and Hanaro Medical Foundation sign a business agreement?

Yes, they signed a business agreement with RSCM, Indonesia's representative national central hospital. This collaboration is highly significant as it is the first partnership between a Korean medical institution and a diagnostic medicine field.

What are the main areas of cooperation with the Indonesian National Central Hospital?

The main areas of cooperation are precision diagnostics, including multi-cancer early screening and genetic testing, and AI-based early diagnosis solutions. Additionally, they plan to jointly utilize medical equipment such as MRI and CT, and prioritize cooperation in mid-to-long-term overseas business areas such as K-healthcare and IT platforms.

What medical services are particularly in high demand in Indonesia?

There is the highest demand for medical services focused on early diagnosis and preventive medicine. Based on this local demand, various business expansions, including health check-ups and data-based medical services, are expected in the future.

What are the expected effects of signing this business agreement?

The biggest expected effects are entry into the Southeast Asian healthcare market and expansion of the global medical network. By expanding business areas based on diagnostic tests and health check-ups, they plan to secure a forward base for medical exports and actively target the Southeast Asian market.

Like